Schizophrenia. Schizophrenia
Conditions
Interventions
Intervention 1: Intervention group 1: In the intervention group, the treatment program will be performed by an experienced group therapist in seven sessions with 15 minutes of rest (three times a wee
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Having diagnostic criteria for schizophrenia disorder, according to DSM 5 Age range between 18 and 50 years Having at least a middle school degree Not receiving electroconvulsive therapy (at least two months before and during hospitalization) Not receiving psychological treatments at the same time as entering the study or 3 months before entering the study Patient and family consent to participate in the study Living with a family member (at least three months before hospitalization)
Exclusion criteria
Exclusion criteria: Patients who are in the acute phase of the disease Patients who are active substance abusers Having serious suicidal thoughts Having any serious medical condition (to prevents further treatment) Mental retardation Brain damage More than one group absence session Comorbidity of substance dependence disorder Comorbidity of other psychiatric disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Metacognitive Beliefs Score in Adrienne Wells Metacognitive Beliefs Questionnaire. Timepoint: Assessment of metacognitive beliefs at the beginning of the study (before the intervention) and after the intervention and three months after the intervention. Method of measurement: Adrienne Wells Metacognitive Beliefs Questionnaire.;Insight level score based on Insight and Treatment Attitudes Questionnaire. Timepoint: Assessment of the patient's level of insight at the beginning of the study (before the intervention) and after the intervention and three months after the intervention. Method of measurement: Insight and Treatment Attitudes Questionnaire.;Score of adherence to treatment on the Medication Adherence Rating Scale. Timepoint: Assessment of patient adherence to treatment at the beginning of the study (before the intervention) and after the intervention and three months after the intervention. Method of measurement: Medication Adherence Rating Scale.;Care pressure level score based on Novak care pressure questionnaire. Timepoint: Assessment of the level of care pressure at the beginning of the study (before the intervention) and after the intervention and three months after the intervention. Method of measurement: Novak Care Pressure Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSamad Fereidooni
Shiraz University of Medical Sciences
Outcome results
None listed